Tag: FDA authorization
Ultrasound That “Breaks” a Tumor Without a Cut
Histotripsy is a non-invasive technique that uses precisely focused ultrasound to mechanically break down a tumor through cavitation microbubbles. In October 2023, the U.S. FDA authorized marketing of the HistoSonics Edison System for liver tumors. Learn what the procedure involves, who it may be suitable for, and what clinical studies show.
